U.S. Buys 200 Million Vaccines from This Company

A growing body of evidence suggests why young children account for only a small percentage of Covid infections. Their immune systems seem better equipped to fend off SARS-CoV-2 than… Read more

Operation Warp Speed’s Biggest Success

The FDA has signaled it plans to approve the Pfizer BioNTech vaccine very soon. This follows the vote at the FDA advisory group of outside scientific advisors on Thursday…. Read more

JP Morgan Issues Tesla Warning

Analysts at JP Morgan just issued an urgent warning . . . Tesla Motors stock is very, very overvalued. The firm rates Tesla Motors stock an “Underperform” – which… Read more

FDA Approves Pfizer Vaccine Today

FDA is widely expected to approve emergency use authorization (EUA) today for the vaccine from Pfizer and BioNTech. In trials, the Pfizer vaccine had an efficacy rate of 95%… Read more

Biden Promises 100 Million Vaccines in 100 Days

One of the first groups of people scheduled to receive Covid vaccinations are residents of nursing homes. Good idea, right? After all, they are likely the most vulnerable among… Read more

DoorDash Shares: Are They Really Worth $102?

$102. That’s the initial public offering price for DoorDash (NYSE: DASH) shares. Yet these prized IPO shares will only be available to +$10 million clients at Goldman Sachs and… Read more

Why Didn’t U.S. Order More Vaccines?

Here’s one thing widely misunderstood about vaccines: They’re much less effective when introduced into a population where coronavirus is running wild. That’s where we are right now in the… Read more

Airbnb and DoorDash: Your IPO Instructions

Airbnb and Doordash. This week the two high-flying Silicon Valley tech companies will go public in initial public offerings. Go here to discover the secret to buying shares –… Read more

The Big Problem with the Pfizer Vaccine

The FDA will decide this week on whether to grant emergency use authorization for the Pfizer vaccine. Next week, it will make a similar decision on the Moderna vaccine. … Read more

To top